advances in knowledge and treatment have raised life expectancy; half of the people diagnosed with CF are expected to live into their 40s, and almost 60% of the people in Canada living with CF are adults. 1 A slightly higher percentage of males are affected by the disease. 1 This is comparable with registry annual reports from other countries such as Australia, Belgium and the USA. [9] [10] [11] Since the majority of individuals with CF are adults, this review will focus on adults aged 18 years and over.
Despite treatment advances, CF remains a life-limiting disease that requires a complex daily regimen of preventive and therapeutic interventions, and may require weekly clinic visits, repeated consultations, and frequent hospitalizations for treatment of pulmonary exacerbations and other CF complications. [12] [13] [14] [15] [16] CF care is normally delivered through specialist medical centers and multidisciplinary teams that include specialist physicians, nurses, dietitians, physiotherapists, respiratory therapists, and pharmacists. 3, [17] [18] [19] This review is expected to provide: findings that further understanding of how adults living with CF experience taking medication for CF or related conditions, and strategies that enhance support for adults living with CF and taking prescribed medication.
Treatments
Cystic fibrosis is a complex disease. Learning to manage all its aspects and treatments can be a daunting task for patients and their caregivers. Individual treatment regimens depend on the stage of the disease and the organs affected. Successful CF management involves not only rigorous daily medication regimens but also a myriad of concurrent critical therapies such as airway clearance, exercise, and nutritional treatments. 3, 17, 18, [19] [20] [21] [22] Cystic fibrosis drastically impacts on the lives of both the affected adults and the family members who provide support and assist with disease management. Family members take on the role of policing medication and treatment regimens which can add to existing responsibilities substantially. 23, 12, 24 Additionally, patients form partnerships with a myriad of providers, including physicians, nurses, dietitians, physiotherapists, pharmacists, respiratory therapists, social workers, and researchers. 10 Despite the complexity and acuity of their disease, adults with CF are expected to become experts in their own care, manage their medications and treatments, and balance the rigorous demands that CF places on the rest of their lives. 16, [24] [25] [26] [27] This is a substantial and arduous responsibility, given the propensity of medication-related adverse events in the Canadian health care system. 28 In addition, the medications typically prescribed for these patients are pivotal to minimizing the adverse and lifethreatening effects of their disease such as malnutrition, airway constriction, reduced pulmonary function, respiratory infection, and ultimately, survival.
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Adherence
The CF literature invariably reports patient non-adherence with medications and treatments yet does not define the concept of adherence. 30 A comprehensive definition was found within the concept analysis of adherence, 31 with the following deemed as the most widely used: "adherence is the extent to which patients follow the instructions they are given for prescribed treatments". 31(p. 635) The concept analysis described the transition from the use of the term compliance to adherence. This coincided with the World Health Organization's adoption of adherence in 2003, 32 in an attempt to move away from the tone of blame imposed on patients labeled non-compliant. The term adherence was believed to imply the patient was in agreement with the prescribed treatment and not simply following orders. 31 However, Bissonnette 31 noted that no definition of adherence truly recognized the patient as a partner in managing care, and called for exploration of the perceptions and understandings of individuals with CF and providers related to adherence.
Adherence rates in the CF population have been studied over several decades with reports dating to the 1950's. Conway, et al. 33 reported treatment compliance at 50% in adults with CF responding to a self-report questionnaire. More recently, variations in rates by treatment have been reported, with adherence to digestive medications at 88.2%, respiratory medications at 61.8%, physiotherapy treatments at 41.2%, and nutritional supplements at 59%. 34 Likewise, Latchford et al. 35 reported adherence to nebulized antibiotics at around 50%. These two groups of researchers had conflicting reports of adherence by age, with Arias Llorente et al. 34 reporting greater adherence in younger patients and Latchford et al. 35 finding the opposite.
More than a decade ago, Abbott and Gee reviewed the literature related to barriers to CF treatment adherence and grouped their findings under four categories: 1) patients reported feeling well and therefore not appreciating the need for treatment; 2) treatments interfered with the social life of people with CF; 3) treatments were too time consuming; and 4) constant treatments make people with CF feel different than others. 36 Further to this, the National Collaborating Centre for Primary Care (NCCP) Consequences of medication non-adherence in CF are significant and well-supported, including disease progression, increased infection rates, and increased direct (e.g. medication waste) and indirect costs (e.g. lost productivity of patients and families). 36 A recent longitudinal retrospective pharmacy medication review of patients aged six and older measured adherence to respiratory medication to predict infection requiring intra-venous (IV) antimicrobials. This study was considered to
be the first to demonstrate that non-adherence to respiratory medication can predict infectious exacerbations of CF symptoms. 29 In 2010, 1,173 people with CF spent 23,146 days in hospital, and 749 courses of home IV antimicrobials were administered for respiratory exacerbations. 1 Overall, the CF literature on adherence and guiding theories continues to locate the responsibility for medication adherence within the individual. A systematic review on the experiences of adults with CF in relation to taking medication has not been found in JBI, PROSPERO, OT Seeker, PEDro or in any of the databases in the proposed search strategy. Conducting this review may reveal individual as well as system factors that could be addressed for the support of taking prescribed medications.
In our discussion of adherence in CF, we covered not only medications but also the nutritional regimens as well as airway clearance techniques that capture the daily work required to maintain optimal health. The review, however, is focused on medication adherence since this topic is largely associated with medication and a comprehensive understanding of what is known about medication adherence from the perspectives of people with CF is necessary.
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Inclusion criteria
Types of participants
This review will consider studies with a focus on adults diagnosed with CF. Specifically, qualitative studies that explore the experiences and perceptions of CF affected adults in relation to their adherence to medication regimens will be included. For the purpose of this study, adults who are aged 18 years and over will be included.
Phenomena of interest
The phenomenon of interest of this qualitative review is the experiences and perceptions of CF affected adults who are taking any prescribed medications to treat their CF and related conditions.
Context
This review will consider qualitative research on community dwelling or hospitalized adults who are diagnosed with CF, and their experiences and perceptions of adherence to medication regimens.
Types of studies
This review will consider qualitative studies that explored the experiences and perceptions of adults living with CF, who are following a prescribed medication regimen. The focus will be on qualitative 
Search strategy
The search strategy aims to find both published and unpublished studies in English and French language from the inception of these databases to present. A three-step search strategy will be utilized in this review. We will undertake an initial limited search of PubMed, CINAHL and PsycINFO and identify a comprehensive list of key words from the text words contained in the title and abstract, and the index terms used to describe the article. Then we will conduct a second search using all identified keywords and index terms across each included database. Thirdly, the reference list of all identified reports and articles will be searched for additional studies. Date limits will not be applied as we want to capture all existing qualitative studies related to the experiences and perceptions of adults who are following medication regimens.
The databases to be searched include: Initial keywords to be used will be:
Cystic fibrosis, medications, drugs, drug management, pharmaceutical regime, young adults, experiences, lived experience, adherence, medication n4 adherence, compliance, medication adherence, medication management, self-management, self-care, self-efficacy, activation, confidence.
Assessment of methodological quality
Papers selected for retrieval will be assessed by two independent reviewers for methodological quality prior to inclusion in the review using standardized critical appraisal instruments from the 
Data collection
Data will be extracted independently by both reviewers from papers included in the review using the standardized data extraction tool from JBI-QARI and NOTARI (Appendices II, IV). The data extracted will include specific details about the phenomenon of interest, populations, study methods and outcomes of significance to the review question and specific objectives.
Data synthesis
Qualitative research findings will, where possible be pooled using JBI-QARI. This will involve the aggregation or synthesis of findings to generate a set of statements that represent that aggregation, through assembling the findings rated according to their quality, and categorizing these findings on the basis of similarity in meaning. These categories are then subjected to a meta-synthesis in order to produce a single comprehensive set of synthesized findings that can be used as a basis for evidencebased practice. Where textual pooling is not possible the findings will be presented in narrative form.
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